Association of Tenascin-C Gene Polymorphisms with Risk of Acute Coronary Syndrome in South Indian Population: A Case−Control Genetic Association Study
- 28 March 2024
- journal article
- research article
- Published by SAGE Publications in Genetic Testing and Molecular Biomarkers
- Vol. 28 (3) , 114-122
Abstract
Background: The extracellular matrix (ECM) glycoprotein changes are associated with the pathogenesis and complications of atherosclerosis, leading to acute coronary syndrome (ACS). Tenascin-C (TNC), an ECM protein, has been implemented in the pathogenesis, diagnosis, and prognosis of patients with cardiovascular disease. Aim: The study aimed to compare the genetic variants of the TNC gene (rs13321, rs2104772, and rs12347433) between South Indians with ACS and healthy participants. Materials and Methods: This case−control study recruited 150 ACS patients as cases and 150 healthy participants as controls. TNC genotyping was performed using TaqMan 5′-exonuclease allele discrimination assay. Serum TNC levels were measured by enzyme-linked immunosorbent assay. Results: Serum TNC levels were significantly higher in cases compared with controls. No significant difference was observed in allele and genotype frequencies of rs13321, rs2104772, and rs12347433 between cases and controls, which was confirmed by dominant, recessive, codominant, and homozygotic genetic models. The patients with heterozygous genotypes of rs13321, rs2104772, and rs12347433 had significantly lower serum TNC levels than patients with respective homozygous genotypes. Haplotype analyses revealed that the C-T-A haplotype in the block of rs13321-rs12347433-rs2104772 was associated with lower ACS risk (OR = 0.33, 95% CI: 0.15 − 0.75; p = 0.005). Also, the C-T-T and G-T-A haplotypes of the TNC gene were associated with higher and lower serum TNC levels, respectively. Conclusion: Our study demonstrated no genetic association between single nucleotide polymorphisms of the TNC gene and ACS risk; however, the C-T-A haplotype of the TNC gene might be associated with reduced ACS risk in South Indians.Keywords
This publication has 37 references indexed in Scilit:
- The prognostic significance of the presence of tenascin-C in patients with stable coronary heart diseaseClinica Chimica Acta, 2022
- Tenascin-C as a noninvasive biomarker of coronary artery diseaseMolecular Biology Reports, 2022
- Diagnosis and Treatment of Acute Coronary SyndromesJAMA, 2022
- Tenascin-C Aggravates Ventricular Dilatation and Angiotensin-Converting Enzyme Activity After Myocardial Infarction in MiceESC Heart Failure, 2020
- Serum tenascin-C is independently associated with increased major adverse cardiovascular events and death in individuals with type 2 diabetes: a French prospective cohortDiabetologia, 2020
- A review on coronary artery disease, its risk factors, and therapeuticsJournal of Cellular Physiology, 2019
- Investigation of variants within the COL27A1 and TNC genes and Achilles tendinopathy in two populationsJournal of Orthopaedic Research, 2012
- Deletion of tenascin-C gene exacerbates atherosclerosis and induces intraplaque hemorrhage in Apo-E-deficient miceCardiovascular Pathology, 2012
- Polymorphic variants in tenascin-C (TNC) are associated with atherosclerosis and coronary artery diseaseHuman Genetics, 2011
- The TIMI Risk Score for Unstable Angina/Non–ST Elevation MIJAMA, 2000